CVS/pharmacy knocks one out of the park with fundraising efforts for ALS
WOONSOCKET, R.I. CVS/pharmacy announced on Friday that it has raised $4.4 million through its annual in-store fundraising campaign for ALS research during the month of June.
This year’s fundraiser, which ran from June 7 to 27, marked the eighth year of the annual fundraising effort. To date, it has raised $19.3 million for ALS research, $1 at a time.
“Each year, we are amazed and grateful for the incredible support CVS/pharmacy customers demonstrate for ALS research,”stated Jonathan Roberts, EVP CVS Caremark, who also served as an honorary chair of this year’s fundraising campaign. “The $19.3 million our dedicated customers have raised, $1 at a time, helps further research into this devastating disease. We hope that today’s check presentation shows how those individual contributions really make a big impact.”
The funds raised from the campaign will be donated to the ALS Therapy Alliance, which was founded in 2000 to coordinate research related to ALS.
ALS, or amyotrophic lateral sclerosis, is a disorder in which there is progressive degeneration of motor nerves in the brain and spinal cord leading to paralysis and death, typically within three to five years. There is no known cause or cure for ALS, which affects 25,000 Americans, with 5,000 new cases diagnosed each year.
The official check presentation will take place prior to the Boston Red Sox versus Yankees game at Fenway Park Friday evening with Tom Ryan, chairman, president and CEO CVS Caremark, participating in the presentation along with Roberts, Troy Brennan, M.D., M.P.H., EVP and chief medical officer of CVS Caremark.
Stiefel zaps acne segment with ‘leave-on’ treatment
DULUTH, Ga. Stiefel Labs, a GlaxoSmithKline company, launched one of the first “leave-on” treatments for acne care, PanOxyl, as a line extension to the company’s acne-care bar and wash.
The formulation is not greasy as compared with spot treatments, and blends into the skin upon application. The new formulation delivers 10% Benzoyl Peroxide in a foam delivery.
In addition to consumer ad support, Stiefel will be fielding its 200-strong dedicated representatives to detail dermatologists.
Stiefel also introduced its Sensitive Sarna eczema itch relief kit, an all-in-one kit that includes a cleanse, itch relief and moisturizer.
New directors elected to NACDS Foundation board
ALEXANDRIA, Va. The National Association of Chain Drug Stores has elected three new directors to the board of the NACDS Foundation.
Jim VanLieshout, VP retail sales with Apotex; Alice Swearingen, VP channel development sales for GlaxoSmithKline; and Chris Dimos, president of pharmacy operations for Supervalu, will fill vacancies on the board, which consists of 22 members.
“We are pleased to welcome the three new members to the NACDS Foundation board of directors,” said Edith Rosato, president of the NACDS Foundation.
“They will continue the strong representation on the board of chains and suppliers alike. We value their expertise, dedication and commitment to the industry, and we look forward to working together for the good of the public and the patients served by community pharmacy.”